Quantification of the effect of GLP-1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model.

导出 LinkOut

翻译打印收藏纠错

作者： Rolien,Bosch ^[1] ; Eric J G,Sijbrands ^[2] ; Nelleke,Snelder ^[3]

作者单位： LAP&P Consultants, Leiden, The Netherlands.;Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. ^[1] Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. ^[2] LAP&P Consultants, Leiden, The Netherlands. ^[3]

主题词人类(Humans);胰高血糖素样肽类(Glucagon-Like Peptides);身体成分(Body Composition);体重(Body Weight);肥胖症(Obesity);模型, 生物学(Models, Biological);体重减轻(Weight Loss);能量摄取(Energy Intake);减肥药(Anti-Obesity Agents);男(雄)性(Male)

DOI 10.1002/psp4.13183

PMID 38867373

发布时间 2024-11-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

CPT: pharmacometrics & systems pharmacology

CPT

2024年13卷9期

1488-1502页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Quantification of the effect of GLP-1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model.

CPT

相似文献

CPT

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Quantification of the effect of GLP-1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model.

CPT

相似文献

CPT

相关期刊

检索历史清除